Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Urology and Nephrology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11255-015-1146-2PMID 26590832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PD14-03 LONG TERM FOLLOW-UP OF A LARGE ACTIVE SURVEILLANCE COHORT

  2014cited by this paper
• 26 Long term follow-up of a large active surveillance cohort

  2014cited by this paper
• Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy‐detectable prostate cancer in patients with PSA level below 20 ng/ml in multi‐core prostate biopsy?

  2013cited by this paper
• The absence of voiding symptoms in men with a prostate‐specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial

  2012cited by this paper
• Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.

  2011cited by this paper
• Associations of benign prostatic hyperplasia with prostate cancer: the debate continues.

  2011cited by this paper
• Reduction of prostate-specific antigen after tamsulosin treatment in patients with elevated prostate-specific antigen and lower urinary tract symptoms associated with low incidence of prostate cancer at biopsy.

  2010cited by this paper
• Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.

  2010cited by this paper
• CLINICAL RESULTS OF LONG TERM FOLLOW-UP OF A LARGE ACTIVE SURVEILLANCE COHORT

  2009cited by this paper
• Using biopsy to detect prostate cancer.

  2008cited by this paper
• The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.

  2007influential reference
• BPH: epidemiology and comorbidities.

  2006cited by this paper
• Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study.

  2005cited by this paper
• Hepatic resection: the last surgical frontier for colorectal cancer.

  2005cited by this paper
• The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection.

  2003cited by this paper
• Prostate cancer detection: relationship to prostate size.

  1999cited by this paper
• The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer.

  1998cited by this paper
• Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels.

  1997cited by this paper
• Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?

  1995cited by this paper
• Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma.

  1994cited by this paper
• The association of benign prostatic hyperplasia and cancer of the prostate

  1992cited by this paper
• Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.

  1992cited by this paper
• The Prostatic Capsule: Does It Exist? Its Importance in the Staging and Treatment of Prostatic Carcinoma

  1989cited by this paper

• Interaction between benign prostatic hyperplasia/prostate size and incidence of prostate cancer: A scoping review and update for practicing urologists

  2025cites this paper
• Combination of prostate cancer antigen 3 (PCA3), sarcosine, glypican-1 (GPC1), urokinase plasminogen activator receptor (uPAR), and thymidine kinase 1 (TK1), and T2WI and DWI radiomics model for distinguishing benign prostatic hyperplasia, prostate cancer, and prostatitis

  2025cites this paper
• Mechanistic role of metal-responsive transcription factor-1 (MTF1) in cadmium-induced prostate carcinogenesis

  2025cites this paper
• Correlation of Prostate-Specific Antigen (PSA), Prostate Volume, and Histology in Ugandan Males

  2025cites this paper
• Transrectal versus transperineal prostate biopsy for cancer detection in patients with gray-zone prostate-specific antigen: a multicenter, real-world study

  2024cites this paper
• New Parametric 2D Curves for Modeling Prostate Shape in Magnetic Resonance Images

  2024cites this paper
• Prostate cancer prediction model: A retrospective analysis based on machine learning using the MIMIC-IV database

  2023cites this paper
• The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3

  2022cites this paper
• Lncap-AI prostate cancer cell line establishment by Flutamide and androgen-free environment to promote cell adherent

  2022cites this paper
• Association Between Prostate Size and MRI Determined Quantitative Prostate Zonal Measurements

  2022cites this paper
• Clinical research analysis based on prostate cancer screening diagnosis

  2022cites this paper
• AKR1B10 expression in benign prostatic hyperplasia and its related mechanism

  2021cites this paper
• Quantitative measurements of prostatic zones by MRI and their dependence on prostate size: possible clinical implications in prostate cancer

  2021cites this paper
• Deep Learning Network for Segmentation of the Prostate Gland With Median Lobe Enlargement in T2-weighted MR Images: Comparison With Manual Segmentation Method.

  2021cites this paper
• Identification of the metabolic signatures of prostate cancer by mass spectrometry‐based plasma and urine metabolomics analysis

  2021cites this paper
• Risk factors, morbidity rates and long-term prognosis in benign hyperplasia and prostate cancer (literature review)

  2021cites this paper
• Any Correlation Between Prostate Volume and Incidence of Prostate Cancer: A Review of Reported Data for the Last Thirty Years

  2021cites this paper
• The Natural History of Patients with Prostate Specific Antigen Elevation Receiving Holmium Laser Enucleation of the Prostate: Prospective Cohort Study

  2021cites this paper
• Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5–10 ng/mL and 10.1–30 ng/mL?

  2020cites this paper
• Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone

  2020cites this paper
• Role of transrectal ultrasound and prostate-specific antigen density in assessment of clinically suspicious prostate cancer

  2020cites this paper
• Diabetes insipidus in patiens with traumatic severe brain injury

  2020cites this paper
• Prostate Specific Antigen and Prostate Volume; How They are Correlated in Patients with Benign Prostatic Hyperplasia

  2020cites this paper
• Prostat Hacmi hem Prostat Kanserini hem de Gleason Skoru 7 veya Üzeri Olan Klinik Olarak Önemli Prostat Kanserini Öngörmede Tek Başına Güçlü Bir Araçtır

  2020cites this paper
• Anatomical Changes of the Peripheral Zone Depending on Benign Prostatic Hyperplasia Size and Their Potential Clinical Implications:A Review for Clinicians.

  2020cites this paper
• Prostate resected weight and postoperative prostate cancer incidence after transurethral resection of the prostate

  2019cites this paper
• Smaller Prostate Volume is Associated with Adverse Pathological Features and Biochemical Recurrence after Radical Prostatectomy

  2019cites this paper
• Histological changes of the peripheral zone in small and large prostates and possible clinical implications

  2019cites this paper
• Management of an Elevated PSA and Biopsy Strategies in the Large Prostate

  2018cites this paper
• Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies

  2018cites this paper
• Effects of Corni Fructus on Testosterone-induced Benign Prostatic Hyperplasia in Sprague Dawley Rats

  2018cites this paper
• Association of benign prostatic hyperplasia (BPH) volume and prostate cancer: consecutive data from an academic institution in respect to the current scientific view

  2017cites this paper
• Neoplasias em contexto de autópsia médico-legal: ainda causa de morte súbita no século XXI?

  2017cites this paper
• Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer

  2016influential citation